Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats
- 5 March 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 316 (3) , 771-780
- https://doi.org/10.1016/j.bbrc.2004.02.110
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Review of Alterations in Endothelial Nitric Oxide Production in DiabetesHypertension, 1998
- Nitric oxide and nitrovasodilators: Similarities, differences, and interactionsThe American Journal of Cardiology, 1996
- Regulation of Endothelial Constitutive Nitric Oxide Synthase by Protein Kinase CHypertension, 1995
- Paracrine function of endothelium-derived nitric oxideLife Sciences, 1995
- Differential Regulation of Constitutive and Inducible Nitric Oxide Production by Inflammatory Stimuli in Murine Endothelial CellsBiochemical and Biophysical Research Communications, 1994
- Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.Hypertension, 1994
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988
- Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic ComplicationsNew England Journal of Medicine, 1987
- Structure of streptozotocinJournal of the American Chemical Society, 1967